Symphony Financial, Ltd. Co. Eli Lilly & CO Transaction History

Symphony Financial, Ltd. Co.

$608 Million
Q3 2024

A detailed history of Symphony Financial, Ltd. Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 5,269 shares of LLY stock, worth $4.76 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

5,269

Previous 4,837 8.93%

Holding current value

$4.76 Million

Previous $4.38 Million 6.6%

% of portfolio

0.77%

Previous 0.8%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $333,564 - $414,728	432 Added 8.93%	5,269 $4.67 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $1.27 Million - $1.59 Million	1,753 Added 56.84%	4,837 $4.38 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $755,055 - $1.01 Million	-1,275 Reduced 29.25%	3,084 $2.4 Million
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $694,826 - $819,108	1,323 Added 43.58%	4,359 $2.54 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $498,166 - $686,797	-1,146 Reduced 27.4%	3,036 $1.63 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $146,960 - $196,502	-419 Reduced 9.11%	4,182 $1.96 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $1 Million - $1.18 Million	3,230 Added 235.59%	4,601 $1.58 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $82,316 - $95,915	-256 Reduced 15.73%	1,371 $0
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $13,934 - $15,879	-47 Reduced 2.81%	1,627 $537,000
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $15,608 - $18,327	-56 Reduced 3.24%	1,674 $541,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $94,580 - $117,538	403 Added 30.37%	1,730 $533,000
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $32,603 - $40,460	145 Added 12.27%	1,327 $361,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $26,370 - $32,452	-119 Reduced 9.15%	1,182 $272,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $107,066 - $138,489	-593 Reduced 31.31%	1,301 $299,000
Q1 2021 Apr 15, 2021	BUY	$164.32 - $212.72 $311,222 - $402,891	1,894 New	1,894 $346,000

Others Institutions Holding LLY

# of Institutions

3,901

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $859B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.

Account

Symphony Financial, Ltd. Co. Eli Lilly & CO Transaction History